WGS Analysis of COVID-19 Positive Patients

Whole Genome Sequencing Analysis of of SARS-CoV-2 Positive Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04353401

Enrollment

Registered

2020-04-20

Start date

2020-08-03

Completion date

2022-03-09

Last updated

2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus Infection, COVID-19

Keywords

Covid-19, WGS, viral load, viral genome

Brief summary

We aim to better understand the mode of action of COVID-19 in the context of its interaction with the host genome through whole-genome sequencing.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Ability and acceptance to provide written informed consent and fluent in English. * Men or women between 18-100+ years, inclusive. * Willing to comply with study procedures. * SARS-CoV-2 positive test result as confirmed by a RT-PCR assay with a sputum or nasopharyngeal sample (either done prior to or at the screening visit).

Design outcomes

Primary

Measure	Time frame	Description
Associations with severity and outcomes	3 months	Clinical associations with human and viral genetics

Countries

United States

Outcome results